Astrid Mayer

1.3k total citations
14 papers, 557 citations indexed

About

Astrid Mayer is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Astrid Mayer has authored 14 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Astrid Mayer's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Research and Treatments (3 papers). Astrid Mayer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Research and Treatments (3 papers). Astrid Mayer collaborates with scholars based in United Kingdom and Austria. Astrid Mayer's co-authors include Heinz Ludwig, E. Fritz, Masafumi Takimoto, Kerry Chester, Richard H. J. Beǵent, Surinder K. Sharma, Berend Tolner, G Boxer, R. Barbara Pedley and John Violet and has published in prestigious journals such as Cancer, Cancer Research and Clinical Cancer Research.

In The Last Decade

Astrid Mayer

13 papers receiving 539 citations

Peers

Countries citing papers authored by Astrid Mayer

Since Specialization

Citations

This map shows the geographic impact of Astrid Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Mayer more than expected).

Fields of papers citing papers by Astrid Mayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Mayer. The network helps show where Astrid Mayer may publish in the future.

Co-authorship network of co-authors of Astrid Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Mayer. A scholar is included among the top collaborators of Astrid Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Mayer. Astrid Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours 2016 ·Endocrine Related Cancer ·(unknown), Amy A. Kirkwood, Julien Edeline, Tu Vinh Luong, Jennifer Watkins, Ángela Lamarca, Doraid Alrifai, (unknown), Roopinder Gillmore, Astrid Mayer, Christina Thirlwell, Debashis Sarker, Juan W. Valle, Tim Meyer	22
2	It starts from any point 2015 ·University of Vienna ·Astrid Mayer	0
3	The Impact of Folfirinox Chemotherapy on the Treatment Pattern of Patients with Pancreas Cancer Seen at a Tertiary Referral Centre in the UK 2014 ·Annals of Oncology ·(unknown), (unknown), (unknown), (unknown), Astrid Mayer, Christina Thirlwell, (unknown), Roopinder Gillmore	2
4	Oxaliplatin/5-Fluorouracil in Advanced Hepatocellular Carcinoma: Case Report and Single-Center Retrospective Review 2014 ·Future Oncology ·Robert M. Goldstein, Dominic Yu, Roopinder Gillmore, Christina Thirlwell, (unknown), Astrid Mayer, Tim Meyer	8
5	Evidence of efficacy of antibody directed enzyme prodrug therapy (ADEPT) in a Phase I trial in patients with advanced carcinoma. 2008 ·Cancer Research ·(unknown), Astrid Mayer, Surinder K. Sharma, Berend Tolner, Roslyn J. Francis, Caroline J. Springer, (unknown), G Boxer, James R. Bell, Alan Green, (unknown), (unknown), (unknown), (unknown), Kerry Chester, Richard H. J. Beǵent	2
6	Abstract LB-200: Evidence of efficacy of antibody directed enzyme prodrug therapy (ADEPT) in a Phase I trial in patients with advanced carcinoma. 2008 ·Cancer Research ·(unknown), Astrid Mayer, Surinder K. Sharma, Berend Tolner, Roslyn J. Francis, Caroline J. Springer, (unknown), G Boxer, James R. Bell, Alan J. Green, (unknown), (unknown), (unknown), (unknown), Kerry Chester, Richard H. J. Beǵent	1
7	A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti–Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug 2006 ·Clinical Cancer Research ·Astrid Mayer, Roslyn J. Francis, Surinder K. Sharma, Berend Tolner, Caroline J. Springer, Jan Martin, G Boxer, James R. Bell, Alan J. Green, John A. Hartley, Clare Cruickshank, (unknown), Kerry Chester, Richard H. J. Beǵent	52
8	Overcoming the immunologic response to foreign enzymes in cancer therapy 2005 ·Expert Review of Clinical Immunology ·Kerry Chester, Matthew Baker, Astrid Mayer	13
9	Engineering Antibodies for Clinical Applications in Cancer 2004 ·Tumor Biology ·Kerry Chester, R. Barbara Pedley, Berend Tolner, John Violet, Astrid Mayer, Surinder K. Sharma, G Boxer, Alan Green, Sylvia Nagl, Richard H. J. Beǵent	46
10	Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer 2000 ·Cancer Chemotherapy and Pharmacology ·Kerry Chester, Astrid Mayer, (unknown), L. Robson, Daniel I. R. Spencer, (unknown), Aiden Flynn, Surinder K. Sharma, (unknown), R. Barbara Pedley, Richard H. J. Beǵent	36
11	Whither high-dose chemotherapy in breast cancer? 2000 ·Breast Cancer Research ·Astrid Mayer, Helena Earl	2
12	Effect of Interferon Alpha-2a on Hormone Receptor Status in Patients with Advanced Breast Cancer 1999 ·Cancer Investigation ·Gabriela Kornek, Angelika Reiner, (unknown), M. Stierer, Astrid Mayer, Heinz Ludwig	6
13	Immunohistochemical Evaluation of Cathepsin D Expression in Colorectal Cancer 1997 ·Cancer Investigation ·Astrid Mayer, E. Fritz, René H. Fortelny, (unknown), Heinz Ludwig	18
14	The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancer 1993 ·Cancer ·Astrid Mayer, Masafumi Takimoto, E. Fritz, (unknown), (unknown), Heinz Ludwig	349

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact